These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9357814)

  • 1. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control.
    Stickle D; Turk J
    Am J Physiol; 1997 Oct; 273(4):E821-30. PubMed ID: 9357814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,5-anhydroglucitol monitoring in diabetes: a mass balance perspective.
    Nerby CL; Stickle DF
    Clin Biochem; 2009 Feb; 42(3):158-67. PubMed ID: 18804100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
    Buse JB; Freeman JL; Edelman SV; Jovanovic L; McGill JB
    Diabetes Technol Ther; 2003; 5(3):355-63. PubMed ID: 12828817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents.
    Yamanouchi T; Akaoka I; Akanuma Y; Akanuma H; Miyashita E
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E423-7. PubMed ID: 2138419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and forensic examinations of glycemic marker 1,5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry.
    Hess C; Stratmann B; Quester W; Madea B; Musshoff F; Tschoepe D
    Forensic Sci Int; 2012 Oct; 222(1-3):132-6. PubMed ID: 22749674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Dungan KM
    Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
    Yamanouchi T; Minoda S; Yabuuchi M; Akanuma Y; Akanuma H; Miyashita H; Akaoka I
    Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aging on plasma 1,5-anhydroglucitol levels in humans and rats.
    Funasako M; Taniji M; Fujimoto K; Ohata M; Higashimoto Y; Uetani K; Suruda T; Nakai S; Fujimoto H; Sakagami Y
    Diabetes Res Clin Pract; 1994 Aug; 25(1):35-41. PubMed ID: 7835210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
    Yamanouchi T; Akanuma Y
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S261-8. PubMed ID: 7859616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol.
    Fortuna D; McCloskey LJ; Stickle DF
    Clin Chim Acta; 2016 Jan; 452():138-41. PubMed ID: 26569347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
    Su H; Ma X; Yin J; Wang Y; He X; Bao Y; Zhou J; Jia W
    Acta Diabetol; 2017 May; 54(5):463-470. PubMed ID: 28210869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computational model of 1,5-AG dynamics during pregnancy.
    Zekavat SM; Butkovich S; Young GJ; Nathan DM; Petrasek D
    Physiol Rep; 2017 Aug; 5(16):. PubMed ID: 28821595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.
    Yamanouchi T; Akanuma H; Nakamura T; Akaoka I; Akanuma Y
    Diabetologia; 1988 Jan; 31(1):41-5. PubMed ID: 3350220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol.
    Fujisawa T; Ikegami H; Tsutsui T; Kawaguchi Y; Ueda H; Shintani M; Nojima K; Kawabata Y; Ono M; Nishino M; Noso S; Yamada K; Babaya N; Ogihara T
    Diabetes Care; 1999 May; 22(5):863-4. PubMed ID: 10332705
    [No Abstract]   [Full Text] [Related]  

  • 15. A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus.
    Namba N; Watanabe F; Tokuda M; Mino M; Furuya E
    Diabetes Res Clin Pract; 1994 May; 24(1):55-61. PubMed ID: 7924887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.
    Won JC; Park CY; Park HS; Kim JH; Choi ES; Rhee EJ; Lee WY; Oh KW; Kim SW; Park SW
    Diabetes Res Clin Pract; 2009 Apr; 84(1):51-7. PubMed ID: 19187997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change of plasma 1,5-anhydro-D-glucitol levels after the onset of diabetes in spontaneous diabetes prone BB/Wor/(/)Tky rats.
    Ishii C; Kawazu S; Utsugi T; Ito Y; Ohno T; Kato N; Tomono S; Nagai R; Komeda K
    Horm Metab Res; 1997 Jan; 29(1):9-11. PubMed ID: 9049646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
    Wang Y; Yuan Y; Zhang Y; Lei C; Zhou Y; He J; Sun Z
    Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients.
    Pitkänen E
    Clin Chim Acta; 1996 Jul; 251(1):91-103. PubMed ID: 8814353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer.
    Nowatzke W; Sarno MJ; Birch NC; Stickle DF; Eden T; Cole TG
    Clin Chim Acta; 2004 Dec; 350(1-2):201-9. PubMed ID: 15530479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.